Gene
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
57158 |
Gene nameGene Name - the full gene name approved by the HGNC.
|
Junctophilin 2 |
Gene symbolGene Symbol - the official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
|
JPH2 |
SynonymsGene synonyms aliases
|
CMD2E, CMH17, JP-2, JP2 |
ChromosomeChromosome number
|
20 |
Chromosome locationChromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
20q13.12 |
SummarySummary of gene provided in NCBI Entrez Gene.
|
Junctional complexes between the plasma membrane and endoplasmic/sarcoplasmic reticulum are a common feature of all excitable cell types and mediate cross talk between cell surface and intracellular ion channels. The protein encoded by this gene is a component of junctional complexes and is composed of a C-terminal hydrophobic segment spanning the endoplasmic/sarcoplasmic reticulum membrane and a remaining cytoplasmic domain that shows specific affinity for the plasma membrane. This gene is a member of the junctophilin gene family. Alternative splicing has been observed at this locus and two variants encoding distinct isoforms are described. [provided by RefSeq, Jul 2008] |
SNPsSNP information provided by dbSNP.
|
SNP ID |
Visualize variation |
Clinical significance |
Consequence |
rs387906897 |
A>G |
Pathogenic |
Genic downstream transcript variant, coding sequence variant, missense variant |
rs387906898 |
G>A |
Pathogenic |
Genic downstream transcript variant, coding sequence variant, missense variant |
rs398124358 |
G>A,C |
Likely-benign, conflicting-interpretations-of-pathogenicity, benign-likely-benign |
Genic downstream transcript variant, coding sequence variant, synonymous variant |
rs531877510 |
C>T |
Likely-benign, conflicting-interpretations-of-pathogenicity, benign-likely-benign |
Genic downstream transcript variant, coding sequence variant, synonymous variant |
rs554853074 |
G>C |
Benign, conflicting-interpretations-of-pathogenicity |
Genic downstream transcript variant, coding sequence variant, missense variant |
rs557878787 |
C>A,T |
Uncertain-significance, conflicting-interpretations-of-pathogenicity |
Genic downstream transcript variant, coding sequence variant, missense variant |
rs587782951 |
G>T |
Uncertain-significance, likely-pathogenic |
Coding sequence variant, missense variant, genic downstream transcript variant |
rs754529157 |
C>T |
Likely-pathogenic |
Coding sequence variant, stop gained |
rs1600482909 |
T>G |
Pathogenic |
Coding sequence variant, missense variant |
|
miRNAmiRNA information provided by mirtarbase database.
|
|
Gene ontology (GO)Gene ontology information of associated ontologies with gene provided by GO database.
|
|
Other IDsOther ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|
Protein
|
UniProt ID |
Q9BR39 |
Protein name |
Junctophilin-2 (JP-2) (Junctophilin type 2) [Cleaved into: Junctophilin-2 N-terminal fragment (JP2NT)] |
Protein function |
[Junctophilin-2]: Membrane-binding protein that provides a structural bridge between the plasma membrane and the sarcoplasmic reticulum and is required for normal excitation-contraction coupling in cardiomyocytes (PubMed:20095964). Provides a structural foundation for functional cross-talk between the cell surface and intracellular Ca(2+) release channels by maintaining the 12-15 nm gap between the sarcolemma and the sarcoplasmic reticulum membranes in the cardiac dyads (By similarity). Necessary for proper intracellular Ca(2+) signaling in cardiac myocytes via its involvement in ryanodine receptor-mediated calcium ion release (By similarity). Contributes to the construction of skeletal muscle triad junctions (By similarity). ; [Junctophilin-2 N-terminal fragment]: Transcription repressor required to safeguard against the deleterious effects of cardiac stress. Generated following cleavage of the Junctophilin-2 chain by calpain in response to cardiac stress in cardiomyocytes. Following cleavage and release from the membrane, translocates to the nucleus, binds DNA and represses expression of genes implicated in cell growth and differentiation, hypertrophy, inflammation and fibrosis. Modifies the transcription profile and thereby attenuates pathological remodeling in response to cardiac stress. Probably acts by competing with MEF2 transcription factors and TATA-binding proteins. |
Family and domains |
Pfam
Accession |
ID |
Position in sequence |
Description |
Type |
PF02493 |
MORN |
14 → 36 |
MORN repeat |
Repeat |
PF02493 |
MORN |
38 → 59 |
MORN repeat |
Repeat |
PF02493 |
MORN |
60 → 78 |
MORN repeat |
Repeat |
PF02493 |
MORN |
82 → 103 |
MORN repeat |
Repeat |
PF02493 |
MORN |
106 → 128 |
MORN repeat |
Repeat |
PF02493 |
MORN |
129 → 151 |
MORN repeat |
Repeat |
PF02493 |
MORN |
291 → 313 |
MORN repeat |
Repeat |
PF02493 |
MORN |
314 → 336 |
MORN repeat |
Repeat |
|
Sequence |
|
Sequence length |
696 |
Interactions |
View interactions |
Associated diseases
|
Disease name |
Disease term |
References |
|
Cardiomyopathies |
|
Cardiomyopathy, Hypertrophic, Familial |
|
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 17 |
17509612, 21216834, 21339484, 17476457, 28393127, 26869393, 15541368, 30235249, 30681346, 23973696, 24001019 |
|
Cardiovascular Diseases |
|
|
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy |
|
|
Left Ventricular Hypertrophy |
|
|